Differing Effects on the Inner Ear of Three Gentamicin Compounds: GM-C1, -C2 and -C1a

Acta Oto-Laryngologica

Volumn 123, Issue 8, 2003, Pages 916-922

  Kobayashi, Masamichi ^a,b,d   Umemura, Masayuki ^c   Sone, Michihiko ^a   Nakashima, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UMEÅ UNIVERSITY   (Sweden)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aminoglycoside; Gentamicin; M ni re's disease; Ototoxicity

Indexed keywords

GENTAMICIN; GENTAMICIN COMPLEX; GENTAMICIN COMPOUND 1; GENTAMICIN COMPOUND 1A; GENTAMICIN COMPOUND 2; GENTAMICIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HAIR CELL; INNER EAR; LABORATORY TEST; MENIERE DISEASE; MORPHOMETRICS; NONHUMAN; NYSTAGMUS; OTOTOXICITY; PRIORITY JOURNAL; SINUSOIDAL ROTATION TEST;

EID: 0242288830     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310000593a     Document Type: Conference Paper

References (25)

1. Schuknecht HF. Ablation therapy in the management of Méniè re's disease. Acta Otolaryngol Suppl (Stockh) 1957; 132: 1-41.
2. Lange G. Gentamicin and other ototoxic antibiotics for the transtympanic treatment of Ménière's disease. Arch Otorhinolaryngol 1989; 246: 269-70.
3. Hirsch BE, Kamerer DB. Role of chemical labyrinthectomy in the treatment of Ménière's disease. Otolaryngol Clin North Am 1997; 30: 1039-49.
4. Blakley BW. Update on intratympanic gentamicin for Méniè re's disease. Laryngoscope 2000; 110: 236-40.
5. Bagger-Sjöbäck D, Bergenius J, Lundberg AM. Inner ear effects of topical gentamicin treatment in patients with Ménière's disease. Am J Otol 1990; 11: 406-10.
6. Wanamaker HH, Gruenwald L, Damm KJ, Ogata Y, Slepecky N. Dose-related vestibular and cochlear effects of transtympanic gentamicin. Am J Otol 1998; 19: 170-9.
7. Nakashima T, Teranishi M, Hibi T, Kobayashi M, Umemura M. Vestibular and cochlear toxicity of aminoglycosides - a review. Acta Otolaryngol 2000; 120: 904-11.
8. Kohlhepp SJ, Loveless MO, Kohnen PW, Houghton DC, Bennett WM, Gilbert DN. Nephrotoxicity of the constituents of gentamicin complex. J Infect Dis 1984; 149: 605-14.
9. Isoherranen N, Lavy E, Soback S. Pharmacokinetics of gentamicin C1, C1a and C2 in beagles after a single intravenous dose. Antimicrob Agents Chemother 2000; 44: 1443-7.
10. Forrey AW, Meijsen-Ludwick BT, O'Neill MA, Maxwell BM, Blair AD, Cutler RE. Nephrotoxicity: a comparison in humans of gentamicin and gentamicin C1 administration. Toxicol Appl Pharmacol 1978; 44: 453-62.
11. Fox KE, Brummett RE, Brown R, Himes D. A comparative study of the ototoxicity of gentamicin and gentamicin C1. Arch Otolaryngol 1980; 106: 44-9.
12. Bock GR, Yates GK, Miller JJ, Moorjani P. Effects of N-acetylcysteine on kanamycin ototoxity in the guinea pig. Hear Res 1996; 743: 337-40.
13. Song BB, Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res 1996; 94: 87-93.
14. Takumida M, Popa R, Anniko M. Free radicals in the guinea pig inner ear following gentamicin exposure. ORL J Otorhinolaryngol Relat Spec 1999; 61: 63-70.
15. Lautermann J, McLaren J, Schacht J. Glutathione protection against ototoxicity depends on nutritional status. Hear Res 1995; 86: 15-24.
16. Song BB, Anderson DJ, Schacht J. Iron chelators protect from aminoglycoside-induced cochleo-and vestibulotoxicity. Free Radic Biol Med 1998; 25: 189-95.
17. Conlon BJ, Aran JM, Erre JP, Smith DW. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant a-lipoic acid. Hear Res 1999; 128: 40-4.
18. Ishikawa K, Matsuzaki Z, Yokomizo M, Terada N, Miyazaki S, Togawa K. Effect of unilateral section of cervical afferent nerve upon optokinetic response and vestibular nystagmus induced by sinusoidal rotation in guinea pigs. Acta Otolaryngol Suppl (Stockh) 1998; 537: 6-10.
19. Attanasio G, Spongr VP, Henderson D. Localization of F-actin and fodrin along the organ of Corti in the chinchilla. Hear Res 1994; 81: 199-207.
20. Saito T, Manabe Y, Honda N, Yamada T, Yamamoto T, Saito H. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc 1995; 9: 271-81.
21. White LO, Lovering A, Reeves DS. Variations in gentamicin C1, C1a, C2, and C2a content of some preparations of gentamicin sulphate used clinically as determined by high-performance liquid chromatography. Ther Drug Monit 1983; 5: 123-6.
22. Isoherranen N, Soback S. Determination of gentamicins C1, C1a, and C2 in plasma and urine by HPLC. Clin Chem 2000; 46: 837-42.
23. Fujiwara Y. Relationships between ototoxicities and chemical structures of ototoxic drug. Nippon Jibiinkoka Gakkai Kaiho 1993; 96: 1482-9.
24. Harada Y, Musso E, Mira E. Action of streptomycin, dihydrostreptomycin, neomycin and kanamycin on the ampullar receptors of the frogs. Acta Otolaryngol (Stockh) 1967; 64: 327-37.
25. Molitoris BA. Cell biology of aminoglycoside nephrotoxicity: newer aspects. Curr Opin Nephrol Hypertens 1997; 6: 384-8.